Sentences with phrase «cellular immunotherapy»
Cellular immunotherapy refers to a type of treatment that uses the body's own immune system to fight against diseases like cancer. It involves modifying or enhancing immune cells in the laboratory and then reintroducing them into the patient's body to help recognize and destroy cancer cells. Full definition
Imaging techniques are becoming ever more important in the fields of cellular immunotherapy and stem - cell transplantation, the researchers say.
sciencedaily.com
«Juno's advanced cellular immunotherapy portfolio and research capabilities strengthen Celgene's global leadership in hematology and adds new drivers for growth beyond 2020.»
He adds: «This knowledge will enable us to significantly enhance cellular immunotherapies by guiding more T cells into a tumor.»
Asterias maintains an extensive global intellectual property portfolio including broad issued claims to fundamental platform technologies including, but not limited to, scalable growth of pluripotent stem cells, methods of production and compositions of matter for several hESC - derived therapeutic cell types, and cellular immunotherapy using the telomerase antigen.
Ana Cunha (Rieber, TUD)-- «Evaluation of D - TMPP for use in diagnosis and specific cellular immunotherapy of prostate cancer» (2007)
Dr. David Maloney, medical director for cellular immunotherapy at Fred Hutch and the Bezos Family Immunotherapy Clinic, talks about the promise of new therapies.
There are plans to open four trials in the immunotherapy clinic for patients with types of solid tumors that have not previously been treated with cellular immunotherapy.
Precious patient samples, contamination concerns, and limited product purification options have compelled manufacturers of cellular immunotherapies (iTx) such as chimeric antigen receptor T cells (CAR - T) and T - cell receptor (TCR) technologies toward the disposables industry.
Asterias Biotherapeutics, Inc. is a biotechnology company dedicated to developing cell - based therapeutics to treat neurological conditions associated with de-myelination and cellular immunotherapies to treat cancer.
FREMONT, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE)-- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell - based therapeutics to treat neurological conditions associated with demyelination and cellular immunotherapies to treat cancer, today provided additional data from the company's ongoing Phase 1 / 2a SCiStar study designed to evaluate the safety and potential efficacy of AST - OPC1 in the treatment of severe cervical spinal cord injury.
Results of 2 cellular immunotherapy trials I'd like to bring your attention to two recently published clinical studies in cancer cellular immunotherapy field.